SG Americas Securities LLC Has $1.56 Million Position in Pediatrix Medical Group, Inc. $MD

SG Americas Securities LLC reduced its holdings in Pediatrix Medical Group, Inc. (NYSE:MD) by 41.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 73,060 shares of the company’s stock after selling 51,082 shares during the period. SG Americas Securities LLC owned approximately 0.09% of Pediatrix Medical Group worth $1,563,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Y Intercept Hong Kong Ltd acquired a new position in shares of Pediatrix Medical Group in the 3rd quarter valued at $513,000. Allianz Asset Management GmbH boosted its position in shares of Pediatrix Medical Group by 158.5% during the 3rd quarter. Allianz Asset Management GmbH now owns 158,777 shares of the company’s stock valued at $2,660,000 after acquiring an additional 97,365 shares in the last quarter. Dana Investment Advisors Inc. increased its stake in Pediatrix Medical Group by 5.6% in the third quarter. Dana Investment Advisors Inc. now owns 801,462 shares of the company’s stock valued at $13,424,000 after acquiring an additional 42,162 shares during the period. Hsbc Holdings PLC increased its stake in Pediatrix Medical Group by 226.6% in the second quarter. Hsbc Holdings PLC now owns 111,997 shares of the company’s stock valued at $1,591,000 after acquiring an additional 77,704 shares during the period. Finally, American Century Companies Inc. raised its position in Pediatrix Medical Group by 38.9% in the third quarter. American Century Companies Inc. now owns 2,682,976 shares of the company’s stock worth $44,940,000 after purchasing an additional 751,109 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on MD shares. Deutsche Bank Aktiengesellschaft set a $19.00 price objective on Pediatrix Medical Group in a report on Friday, February 20th. UBS Group lowered their target price on shares of Pediatrix Medical Group from $23.00 to $22.00 and set a “neutral” rating on the stock in a report on Tuesday, February 24th. Jefferies Financial Group raised shares of Pediatrix Medical Group to a “strong-buy” rating in a report on Thursday, March 12th. Weiss Ratings restated a “hold (c+)” rating on shares of Pediatrix Medical Group in a research report on Friday, March 27th. Finally, Truist Financial decreased their price objective on shares of Pediatrix Medical Group from $24.00 to $21.00 and set a “hold” rating on the stock in a research note on Thursday, February 19th. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $19.80.

Pediatrix Medical Group Stock Up 2.4%

Shares of NYSE MD opened at $21.69 on Tuesday. Pediatrix Medical Group, Inc. has a 52-week low of $11.84 and a 52-week high of $24.99. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.66 and a current ratio of 1.66. The stock has a market cap of $1.80 billion, a P/E ratio of 11.18 and a beta of 0.72. The firm has a 50 day moving average price of $20.47 and a 200 day moving average price of $20.48.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings data on Thursday, February 19th. The company reported $0.50 EPS for the quarter, missing the consensus estimate of $0.53 by ($0.03). Pediatrix Medical Group had a return on equity of 19.59% and a net margin of 8.64%.The business had revenue of $493.77 million for the quarter, compared to analyst estimates of $486.23 million. During the same period in the previous year, the business posted $0.51 EPS. The business’s quarterly revenue was down 1.7% compared to the same quarter last year. Analysts expect that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.